Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Mesoblast Ltd.
DescriptionAllogeneic mesenchymal precursor cells (MPCs) injected into a damaged disc in an outpatient procedure
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard Indication Musculoskeletal (unspecified)
Indication DetailsTreat chronic low back pain due to degenerative disc disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today